# S1602: Different Strains of BCG With or Without Vaccine in High Grade Non- Muscle Invasive Bladder Cancer

> **NCT03091660** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **SWOG Cancer Research Network** · enrollment: 1000 (actual)

## Conditions studied

- Stage 0 Bladder Urothelial Carcinoma
- Stage 0is Bladder Urothelial Carcinoma
- Stage I Bladder Urothelial Carcinoma

## Interventions

- **BIOLOGICAL:** BCG Solution
- **BIOLOGICAL:** BCG Tokyo-172 Strain Solution
- **BIOLOGICAL:** BCG Tokyo-172 Strain Vaccine
- **OTHER:** Laboratory Biomarker Analysis

## Key facts

- **NCT ID:** NCT03091660
- **Lead sponsor:** SWOG Cancer Research Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2017-02-24
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-06-15
- **Target enrollment:** 1000 (ACTUAL)
- **Last updated:** 2026-03-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03091660

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03091660, "S1602: Different Strains of BCG With or Without Vaccine in High Grade Non- Muscle Invasive Bladder Cancer". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT03091660. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*